Healthcare -
Biotechnology - NASDAQ - US
$ 28.395
1.41 %
$ 2.69 B
Market Cap
-18.93
P/E
EWTX - COST OF REVENUE
Cost of Revenue EWTX - Edgewise Therapeutics, Inc.
1.73 M
LAST VALUE
152.34%
2 YEAR CAGR
0.00%
5 YEAR CAGR
0.00%
10 YEAR CAGR